![No image](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1669444-50-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | PF 05214030 REF: 3D-BP180194CAS: 1669444-50-1 | Min. 95% | 475.00 €~1,878.00 € | Thu 13 Mar 25 |
![]() | PF-05214030 REF: TM-T70299CAS: 1669444-50-1 | - - - | 1,444.00 €~2,375.00 € | Tue 22 Apr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
PF 05214030
CAS:1669444-50-1
PF 05214030 is an investigational drug that has been shown to reduce the number of …
Formula:
C17H13Cl2FN2O4S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
431.3 g/mol
Ref: 3D-BP180194
1mg | 475.00 € | ||
2mg | 676.00 € | ||
5mg | 1,047.00 € | ||
10mg | 1,515.00 € | ||
25mg | 1,878.00 € |
Estimated delivery in United States, on Thursday 13 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
PF-05214030
CAS:1669444-50-1
PF-05214030 is a novel potent TRPV4 antagonist (hTRPV4 IC50 4nM; rTRPV4 IC50 27nM).
Formula:
C17H13Cl2FN2O4S
Color and Shape:
Liquid
Molecular weight:
431.27
Ref: TM-T70299
25mg | 1,444.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025